These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31324723)

  • 61. Decreased IL-4 producing CD4+ T cells in patients with active systemic lupus erythematosus-relation to IL-12R expression.
    Sugimoto K; Morimoto S; Kaneko H; Nozawa K; Tokano Y; Takasaki Y; Hashimoto H
    Autoimmunity; 2002 Sep; 35(6):381-7. PubMed ID: 12568118
    [TBL] [Abstract][Full Text] [Related]  

  • 62. IFN-γ licenses CD11b(+) cells to induce progression of systemic lupus erythematosus.
    Shaabani N; Honke N; Dolff S; Görg B; Khairnar V; Merches K; Duhan V; Metzger S; Recher M; Barthuber C; Hardt C; Proksch P; Häussinger D; Witzke O; Lang PA; Lang KS
    J Autoimmun; 2015 Aug; 62():11-21. PubMed ID: 26094774
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Expression and clinical significance of inducible co-stimulator on peripheral blood T lymphocyte subsets in patients with systemic lupus erythematosus].
    Yang JH; Shen Q; Zhao DB; Cai Q; Han XH
    Zhonghua Yi Xue Za Zhi; 2005 Feb; 85(5):318-23. PubMed ID: 15854508
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Interferon-alpha in systemic lupus erythematosus.
    Crow MK; Kirou KA
    Curr Opin Rheumatol; 2004 Sep; 16(5):541-7. PubMed ID: 15314491
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus.
    Gergely P; Niland B; Gonchoroff N; Pullmann R; Phillips PE; Perl A
    J Immunol; 2002 Jul; 169(2):1092-101. PubMed ID: 12097418
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus.
    Bortoluzzi A; Vincenzi F; Govoni M; Padovan M; Ravani A; Borea PA; Varani K
    Arthritis Res Ther; 2016 Aug; 18(1):192. PubMed ID: 27566294
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Decreased production of interleukin-12 and other Th1-type cytokines in patients with recent-onset systemic lupus erythematosus.
    Horwitz DA; Gray JD; Behrendsen SC; Kubin M; Rengaraju M; Ohtsuka K; Trinchieri G
    Arthritis Rheum; 1998 May; 41(5):838-44. PubMed ID: 9588735
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CD8+iTregs attenuate glomerular endothelial cell injury in lupus-prone mice through blocking the activation of p38 MAPK and NF-κB.
    Liu Y; Deng W; Meng Q; Qiu X; Sun D; Dai C
    Mol Immunol; 2018 Nov; 103():133-143. PubMed ID: 30268079
    [TBL] [Abstract][Full Text] [Related]  

  • 69. TNFAIP3 downregulation mediated by histone modification contributes to T-cell dysfunction in systemic lupus erythematosus.
    Zhao H; Wang L; Luo H; Li QZ; Zuo X
    Rheumatology (Oxford); 2017 May; 56(5):835-843. PubMed ID: 28158872
    [TBL] [Abstract][Full Text] [Related]  

  • 70. In vivo anti-inflammatory activities of novel cytokine IL-38 in Murphy Roths Large (MRL)/lpr mice.
    Chu M; Tam LS; Zhu J; Jiao D; Liu H; Cai Z; Dong J; Kai Lam CW; Wong CK
    Immunobiology; 2017 Mar; 222(3):483-493. PubMed ID: 27769564
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Systemic IFN-alpha drives kidney nephritis in B6.Sle123 mice.
    Fairhurst AM; Mathian A; Connolly JE; Wang A; Gray HF; George TA; Boudreaux CD; Zhou XJ; Li QZ; Koutouzov S; Banchereau J; Wakeland EK
    Eur J Immunol; 2008 Jul; 38(7):1948-60. PubMed ID: 18506882
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Systemic lupus erythematosus favors the generation of IL-17 producing double negative T cells.
    Li H; Adamopoulos IE; Moulton VR; Stillman IE; Herbert Z; Moon JJ; Sharabi A; Krishfield S; Tsokos MG; Tsokos GC
    Nat Commun; 2020 Jun; 11(1):2859. PubMed ID: 32503973
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Monoclonal anti-double-stranded DNA autoantibody stimulates the expression and release of IL-1beta, IL-6, IL-8, IL-10 and TNF-alpha from normal human mononuclear cells involving in the lupus pathogenesis.
    Sun KH; Yu CL; Tang SJ; Sun GH
    Immunology; 2000 Mar; 99(3):352-60. PubMed ID: 10712664
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Autoantibody-Positive Healthy Individuals Display Unique Immune Profiles That May Regulate Autoimmunity.
    Slight-Webb S; Lu R; Ritterhouse LL; Munroe ME; Maecker HT; Fathman CG; Utz PJ; Merrill JT; Guthridge JM; James JA
    Arthritis Rheumatol; 2016 Oct; 68(10):2492-502. PubMed ID: 27059145
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide.
    Sharabi A; Lapter S; Mozes E
    J Autoimmun; 2010 Mar; 34(2):87-95. PubMed ID: 19596183
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells.
    Wu HY; Quintana FJ; Weiner HL
    J Immunol; 2008 Nov; 181(9):6038-50. PubMed ID: 18941193
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The detrimental effects of IFN-α on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction.
    Thacker SG; Berthier CC; Mattinzoli D; Rastaldi MP; Kretzler M; Kaplan MJ
    J Immunol; 2010 Oct; 185(7):4457-69. PubMed ID: 20805419
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus.
    Blomberg S; Eloranta ML; Cederblad B; Nordlin K; Alm GV; Rönnblom L
    Lupus; 2001; 10(7):484-90. PubMed ID: 11480846
    [TBL] [Abstract][Full Text] [Related]  

  • 79. NETs decorated with bioactive IL-33 infiltrate inflamed tissues and induce IFN-α production in patients with SLE.
    Georgakis S; Gkirtzimanaki K; Papadaki G; Gakiopoulou H; Drakos E; Eloranta ML; Makridakis M; Kontostathi G; Zoidakis J; Baira E; Rönnblom L; Boumpas DT; Sidiropoulos P; Verginis P; Bertsias G
    JCI Insight; 2021 Nov; 6(21):. PubMed ID: 34554930
    [TBL] [Abstract][Full Text] [Related]  

  • 80. IL-17 in systemic lupus erythematosus.
    Crispín JC; Tsokos GC
    J Biomed Biotechnol; 2010; 2010():943254. PubMed ID: 20379379
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.